Comparing highly efficacious antimalarial drugs.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 19018659.
- Also identified by DOI 10.1371/journal.pmed.0050228 and PMC identifier 2586357.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Colin Sutherland discusses a Policy Forum article that explores the design and standardization of pre-licensure phase III antimalarial treatment trials.
Medical subject headings
- Antimalarials
- Malaria, Falciparum